Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
Centre Hospitalier Sud Francilien
30 participants
Mar 28, 2024
OBSERVATIONAL
Conditions
Summary
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
Eligibility
Inclusion Criteria5
- Older than 18 years patient with type 1 or 2 diabetes
- Treated with multiple insulin injections
- Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before
- Dependent on a health professional for treatment management.
- Subject informed of the study and not objecting to data collection.
Exclusion Criteria1
- \- Patient refusing study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Advice on the proper use of insulin therapy will be given, if necessary, to caregivers. Patients are reviewed at 1 month of this first visit with a collection of the same data
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06192940